Switch to:
More From Other Websites
PharmAthene Receives $5.8 Million Payment From BARDA Apr 13 2015
PHARMATHENE, INC Financials Mar 18 2015
PharmAthene Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign... Mar 15 2015
PHARMATHENE, INC Files SEC form 10-K, Annual Report Mar 11 2015
PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Mar 09 2015
PharmAthene reports 4Q loss Mar 09 2015
PharmAthene Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign... Mar 09 2015
Eli Lilly CEO: Big pharma needs to change its strategy Mar 04 2015
PharmAthene rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax... Feb 02 2015
PharmAthene rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax... Feb 02 2015
Siga Must Pay Total of $194 Million in Smallpox-Drug Case Jan 15 2015
PharmAthene Awarded $195 Million Plus Post-Judgment Interest By Delaware Court Of Chancery Jan 15 2015
PHARMATHENE, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 12 2015
Delaware Court of Chancery Issues Order Specifying Amount Of Lump Sum Expectation Damages Payable To... Jan 07 2015
Delaware court orders Siga to pay PharmAthene $113 mln Jan 07 2015
Amgen announces treatment to compete with Juno, other Seattle biotechs as it exits region Jan 05 2015
PharmAthene Fulfills Valortim® IDIQ Contract Nov 20 2014
PharmAthene Fulfills Valortim® IDIQ Contract Nov 20 2014
PHARMATHENE, INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 06 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK